Buhlmann Diagnostics Corp Archives - Buhlmann Diagnostics Corp

Integration of Controls into BUHMANN Quantum Blue® Assays

Quantum Blue® Lateral Flow Assays: Simple, Fast, Accurate Quantitative Results Now Even More Convenient with 2 Lot Specific Ready-to-use Controls! Available NOW with Integrated Controls: Quantum Blue® Infliximab Assay The BÜHLMANN Quantum Blue® Infliximab is the ONLY quantitative rapid test in the market for infliximab that can provide fast, reliable information for infliximab. The test is designed for the selective

BUHLMANN LabSense News: Winter 2017 Edition

BUHLMANN Diagnostics Corp is proud to release the second edition of our newsletter. View the latest information, new happenings, products highlights, citations, and promotions in the BUHLMANN LabSense News. Here you will also be able to access valuable resources, applications, and other newsworthy items specific to fields of in vitro diagnostics and scientific research. In this edition we

Connect with BUHLMANN Diagnostics Corp at CDDW 2017

Canadian Digestive Diseases Week (CDDW) 2017 BUHLMANN Diagnostics Corp Booth: #1032 Mar 03 – 06, 2017 LOCATION The Fairmont Banff Springs Banff, Alberta LEARN MORE Click & Contact CDDW 2017 BUHLMANN Team Connect with our team ahead of time, learn more about our Calprotectin Assays or schedule a meeting! COLLIN SHAW VP of Business Development

Safe Use of Stool Extracts on Clinical Chemistry Analyzers

BÜHLMANN fCAL® turbo is for Research Use Only. Not to be used in diagnostic procedures. Health Canada License: 96808 BÜHLMANN fCAL® turbo Stool extracts used in the BÜHLMANN fCAL® turbo on clinical chemistry analyzers can be applied without any concern of system contamination. BÜHLMANN investigated this new sample matrix with the goal to exclude potential risks.

The Utility of Fecal Calprotectin in the Real-World Clinical Care of Patients with Inflammatory Bowel Disease

BÜHLMANN Quantum Blue® fCAL Citation: Abej, E. et al. The Utility of Fecal Calprotectin in the Real-World Clinical Care of Patients with Inflammatory BowelDisease Can J Gastroenterol Hepatol. 2016;2016:2483261. Epub 2016 Sep 28.DOI:10.1155/2016/2483261. PMID: 27774443. This Canadian study represents how FCAL testing is utilized in the field for monitoring disease activity in IBD. The reference for the cut-off

Evaluation of the BÜHLMANN fCAL® turbo Test at Bioanalytica Lucerne

BÜHLMANN fCAL® turbo is for Research Use Only in the US. Not to be used in diagnostic procedures. Health Canada License: 96808 French Version Interview with Yvonne Schallberger, Bioanalytica Lucerne Mrs. Schallberger, you recently decided to introduce the new calprotectin assay, BÜHLMANN fCAL® turbo, which offers a calprotectin result in random access mode on all USUAL

BUHLMANN Highlights – ACE Kinetic Enzymatic Assay

BÜHLMANN ACE Kinetic Enzymatic Assay Simple, Fast, Versatile Automated Assay for use on Multiple Clinical Chemistry Platforms ACE kinetic is FDA 510(k) cleared. For in vitro Diagnostic Use. BÜHLMANN's Clinical Chemistry product line is a unique selection of high quality assays for routine and specialized testing in clinical chemistry. Employing the long lasting experience with ACE activity on

BUHLMANN Flow CAST Kinase Inhibition Assay and Utilization in Research

BÜHLMANN's Kinase Inhibition Assay has been utilized in several publications in various fields of study such as drug discovery, cancer research, autoimmune disease research, and more. Several key kinases that are molecular targets in drug discovery, such as PI3Kγ and PI3Kδ, SYK, BTK are main components in the basophil activation signaling pathways. Our Assay has been

FOCUS: Future of Fecal Calprotectin Utility Study in Inflammatory Bowel Disease

BÜHLMANN Quantum Blue® fCAL Citation: Rosenfeld G, Greenup A-J, Round A, et al. FOCUS: Future of fecal calprotectin utility study in inflammatory bowel disease. World Journal of Gastroenterology. 2016;22(36):8211-8218. doi:10.3748/wjg.v22.i36.8211. PMID:27688663. Highlight from this Publication "The FC test effected a change in management 51.3% of the time and receipt of the result was associated with a reduction

BUHLMANN Highlights: Neuroimmune Biomarkers, Esoteric Testing, and Utilization in Research

BÜHLMANN Neuroimmunology Assays Simple, Esoteric Testing for Important Neuroimmune Biomarkers The BÜHLMANN Neuroimmunology product line is a list of robust assays for simple, esoteric testing for important neuroimmune biomarkers and it is supported by numerous clinical publications. Learn More About: Benefits, Features and Highlights of BÜHLMANN Neuroimmunology Assays BÜHLMANN Assay Kit Citations- See how these assays were used

Category: Buhlmann Diagnostics Corp

Integration of Controls into BUHMANN Quantum Blue® Assays

BUHLMANN LabSense News: Winter 2017 Edition

Connect with BUHLMANN Diagnostics Corp at CDDW 2017

Safe Use of Stool Extracts on Clinical Chemistry Analyzers

The Utility of Fecal Calprotectin in the Real-World Clinical Care of Patients with Inflammatory Bowel Disease

Evaluation of the BÜHLMANN fCAL® turbo Test at Bioanalytica Lucerne

BUHLMANN Highlights – ACE Kinetic Enzymatic Assay

BUHLMANN Flow CAST Kinase Inhibition Assay and Utilization in Research

FOCUS: Future of Fecal Calprotectin Utility Study in Inflammatory Bowel Disease

BUHLMANN Highlights: Neuroimmune Biomarkers, Esoteric Testing, and Utilization in Research

ABOUT US

SOCIAL MEDIA

QUICK LINKS

CONTACT US